These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 8958806)

  • 1. Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value.
    Väisänen A; Tuominen H; Kallioinen M; Turpeenniemi-Hujanen T
    J Pathol; 1996 Nov; 180(3):283-9. PubMed ID: 8958806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma.
    Väisänen A; Kallioinen M; Taskinen PJ; Turpeenniemi-Hujanen T
    J Pathol; 1998 Sep; 186(1):51-8. PubMed ID: 9875140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
    Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
    J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and serum levels of MMP-2 and MMP-9 during human melanoma progression.
    Redondo P; Lloret P; Idoate M; Inoges S
    Clin Exp Dermatol; 2005 Sep; 30(5):541-5. PubMed ID: 16045689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.
    Simonetti O; Lucarini G; Brancorsini D; Nita P; Bernardini ML; Biagini G; Offidani A
    Cancer; 2002 Nov; 95(9):1963-70. PubMed ID: 12404291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the prognostic value of matrix metalloproteinases 2 and 9 in cutaneous melanoma.
    Väisänen AH; Kallioinen M; Turpeenniemi-Hujanen T
    Hum Pathol; 2008 Mar; 39(3):377-85. PubMed ID: 18187184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of matrilysin (matrix metalloproteinase-7) in primary cutaneous and metastatic melanoma.
    Kawasaki K; Kawakami T; Watabe H; Itoh F; Mizoguchi M; Soma Y
    Br J Dermatol; 2007 Apr; 156(4):613-9. PubMed ID: 17493064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cyclooxygenase-2 in benign naevi and during human cutaneous melanoma progression.
    Kuźbicki L; Sarnecka A; Chwirot BW
    Melanoma Res; 2006 Feb; 16(1):29-36. PubMed ID: 16432453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas.
    Airola K; Karonen T; Vaalamo M; Lehti K; Lohi J; Kariniemi AL; Keski-Oja J; Saarialho-Kere UK
    Br J Cancer; 1999 May; 80(5-6):733-43. PubMed ID: 10360651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nevus associated malignant melanomas--diagnostic validation and prognosis].
    Stadler R; Garbe C
    Hautarzt; 1991 Jul; 42(7):424-9. PubMed ID: 1938395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of activated matrix metalloproteinase-2 (MMP-2) as the main gelatinolytic enzyme in malignant melanoma by in situ zymography.
    Kurschat P; Wickenhauser C; Groth W; Krieg T; Mauch C
    J Pathol; 2002 Jun; 197(2):179-87. PubMed ID: 12015741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micro-anatomy related antigen expression in melanocytic lesions.
    Meije CB; Mooi WJ; Le Poole IC; Van Muijen GN; Das PK
    J Pathol; 2000 Apr; 190(5):572-8. PubMed ID: 10727983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].
    Pluot M; Joundi A; Grosshans E
    Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of matrix metalloproteinase-2 and -9 and membrane-type 1 matrix metalloproteinase in melanocytic tumors of dogs and canine melanoma cell lines.
    Docampo MJ; Cabrera J; Rabanal RM; Bassols A
    Am J Vet Res; 2011 Aug; 72(8):1087-96. PubMed ID: 21801067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.
    Fröhlich E; Mack AF; Garbe C; Klessen C
    Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum matrix metalloproteinase-8 is associated with ulceration and vascular invasion of malignant melanoma.
    Vihinen P; Koskivuo I; Syrjänen K; Tervahartiala T; Sorsa T; Pyrhönen S
    Melanoma Res; 2008 Aug; 18(4):268-73. PubMed ID: 18626311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinate expression of membrane type-matrix metalloproteinases-2 and 3 (MT2-MMP and MT3-MMP) and matrix metalloproteinase-2 (MMP-2) in primary and metastatic melanoma cells.
    Ohnishi Y; Tajima S; Ishibashi A
    Eur J Dermatol; 2001; 11(5):420-3. PubMed ID: 11525948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase-2 (MMP-2) immunoreactive protein--a new prognostic marker in uveal melanoma?
    Väisänen A; Kallioinen M; von Dickhoff K; Laatikainen L; Höyhtyä M; Turpeenniemi-Hujanen T
    J Pathol; 1999 May; 188(1):56-62. PubMed ID: 10398141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced expression of p16 and p27 is correlated with tumour progression in cutaneous melanoma.
    Sanki A; Li W; Colman M; Karim RZ; Thompson JF; Scolyer RA
    Pathology; 2007 Dec; 39(6):551-7. PubMed ID: 18027257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.